checkAd
    Startseite > Aktien > Lumos Pharma > Nachrichten
    Lumos Pharma Aktie
    2,2500
     
    USD
    -1,75 %
    -0,0400 USD
    Letzter Kurs 01.06.24 Nasdaq
    2,2300
     
    USD
    400 STK
    Geldkurs 31.05.24
    2,3500
     
    USD
    800 STK
    Briefkurs 31.05.24
    ISIN: US55028X1090 · WKN: A2P12E · SYM: LUMO · USA

    Neueste Nachrichten

    Lumos Pharma Announces Abstracts Accepted for Presentation at ENDO 2024
    20.05.24 · globenewswire · Lumos Pharma
    Lumos Pharma Announces Positive End-of-Phase 2 Meeting with FDA and Reports First Quarter 2024 Financial Results
    14.05.24 · globenewswire · Lumos Pharma
    Lumos Pharma to Report First Quarter 2024 Financial Results and Provide Clinical Update on May 15, 2024
    09.05.24 · globenewswire · Lumos Pharma
    Lumos Pharma Announces Abstracts Accepted for Presentation at Upcoming Medical Meetings
    18.04.24 · globenewswire · Lumos Pharma
    Lumos Pharma Announces that the USPTO Has Granted Patent Protection for Novel Formulation of LUM-201, Extending Exclusivity to 2042
    20.03.24 · globenewswire · Lumos Pharma
    Lumos Pharma Reports Full Year 2023 Financial Results and Provides Clinical Development Update
    07.03.24 · globenewswire · Lumos Pharma
    Lumos Pharma to Report Full Year 2023 Financial Results and Host Conference Call on March 7, 2024
    26.02.24 · globenewswire · Lumos Pharma
    Lumos Pharma to Participate in Oppenheimer’s 34th Annual Healthcare Life Sciences Conference
    05.02.24 · globenewswire · Lumos Pharma
    Lumos Pharma Promotes Pisit “Duke” Pitukcheewanont, MD to Chief Medical Officer
    04.01.24 · globenewswire · Lumos Pharma
    Lumos Pharma to Host Virtual Key Opinion Leader Webinar to Discuss Phase 2 OraGrowtH Trial Data and Treatment Potential of Oral LUM-201 for Pediatric Growth Hormone Deficiency
    21.11.23 · globenewswire · Lumos Pharma
    Lumos Pharma Announces Participation in the Piper Sandler 35th Annual Healthcare Conference in November
    20.11.23 · globenewswire · Lumos Pharma
    Lumos Pharma Reports Third Quarter 2023 Financial Results and Clinical Development Updates
    07.11.23 · globenewswire · Lumos Pharma